Appropriate Use Criteria for Imaging Evaluation of Biochemical Recurrence of Prostate Cancer After Definitive Primary Treatment
J Nucl Med
.
2020 Apr;61(4):552-562.
doi: 10.2967/jnumed.119.240929.
Authors
Hossein Jadvar
1
,
Leslie K Ballas
2
,
Peter L Choyke
3
,
Stefano Fanti
4
,
James L Gulley
5
,
Ken Herrmann
4
,
Thomas A Hope
1
,
Alan K Klitzke
6
,
Jorge D Oldan
1
3
,
Martin G Pomper
7
,
Steven P Rowe
1
,
Rathan M Subramaniam
6
8
,
Samir S Taneja
9
,
Herbert Alberto Vargas
3
,
Sukhjeet Ahuja
10
Affiliations
1
Society of Nuclear Medicine and Molecular Imaging, Reston, Virginia.
2
American Society for Radiation Oncology, Arlington, Virginia.
3
American Society of Clinical Oncology, Alexandria, Virginia.
4
European Association of Nuclear Medicine, Vienna, Austria.
5
American College of Physicians, Philadelphia, Pennsylvania.
6
American College of Nuclear Medicine, Reston, Virginia.
7
World Molecular Imaging Society, Culver City, California.
8
American College of Radiology, Reston, Virginia; and.
9
American Urological Association, Linthicum Heights, Maryland.
10
Society of Nuclear Medicine and Molecular Imaging, Reston, Virginia sahuja@snmmi.org.
PMID:
32238495
DOI:
10.2967/jnumed.119.240929
No abstract available
MeSH terms
Diagnostic Imaging / standards*
Humans
Male
Neoplasm Staging
Prostatic Neoplasms / diagnostic imaging*
Prostatic Neoplasms / metabolism
Prostatic Neoplasms / therapy*
Recurrence
Reference Standards